Dan Chapman, PhD, is part of the leadership team within Informatics at UCB with responsibility for Software Development and Architecture and Therapeutic Informatics (UK).

Dr. Chapman has 15 years’ experience working within the Pharmaceutical industry in a variety of roles.

After completing a PhD in Chemistry at Warwick University, he transitioned to informatics during post-doctoral research at Cambridge University as part of the CLIC consortium.  Dr. Chapman joined AstraZeneca in 1997 and worked on a variety of global projects before joining UCB in his present role in 2005.

Since then, he has driven several projects to revolutionize the informatics platform within UCB and is currently actively involved in promoting Data Science across UCB.

Dr. Chapman had served as the PRISME Forum Chair between 2018-2023.

Shubha Chaudhari is a senior entrepreneurial informatics leader with over 20 years broad based management experience leading business and technology function growth. She is accomplished in directing the strategic application of end to end technologies to advance business priorities and leading complex transformations in multi-national corporations. Empowering team builder and coach, Shubha is skilled at harnessing organization talents to orchestrate and deliver complex initiatives within time and resource constraints.

Shubha is a recognized leader at building start-up units in diverse organizational ecosystems. A technologist who can lead and deliver specialized functional objectives with impactful positive outcome, she is committed to lifelong learning and forever readiness to stretch beyond core competencies.

Martin Erkens, PhD, leads the Pharma Research and Early Development Informatics organization (pREDi) of Roche. Data science supporting drug projects as well as Research and Early Development workflow solutions are among the key contributions of Dr. Erken’s organization. He was responsible for supporting multiple mergers and acquisitions, implementing a wide range of diverse solution including a digital media environment for early development, a research imaging data warehouse, a efficient data review tool for early clinical studies and a LIMS for the omics labs.

Prior to becoming head of pREDi, Dr. Erkens ran various IT teams in the clinical space and was responsible to implement global systems for drug project and portfolio planning, global sales reporting, electronic data capture of clinical trials (the first large cloud system at Roche), clinical imaging and a system environment for the internal clinical Phase I unit. During this time he also led a program establishing a complete new blue print of the system landscape supporting clinical development resulting in an investment program over 5 years and 100+ mUSD investment.

Dr. Erkens received his PhD in Mathematics (stability theory) from Albert Ludwigs Universität, Freiburg. He also holds two degrees in Mathematics and Physics (“Diplom” and “Staatsexamen”) from the same university.

Dr. Erkens was elected PRISME Forum Board of Directors’ Chair on November 15, 2023.

Lars Greiffenberg, PhD, MS, holds a MS in Biology and a PhD in Microbiology and has more than 15 years of experience in the field of integrated R&D IT solutions and translational informatics. He held different R&D IT management positions at Aventis Pharma and Sanofi-Aventis in Frankfurt before relocating to the Sanofi site in Toulouse, France where he was Global Head of Solution Center Translational Medicine with responsibility to manage and lead a global program to enable translational science at Sanofi.

In 2014 he joined AbbVie in Ludwigshafen (Germany) as director of R&D IT and Translational Informatics. In this role he is heading business IT support covering data and solutions from early discovery up to Medical Affairs. In 2017 he extended his responsibilities including now global Library Sciences at Abbvie. He is driven by the ambition to transform the way we access, consume and leverage literature in the future. He recently established a team at AbbVie, dedicated to use modern methods and algorithms to extract and visualize mechanistic disease information from literature content.

In 2018 he further enlarged his area of responsibility to incorporate the Academic Partnerships Organization which is leveraging an AbbVie-Campus at the University of Illinois Urbana-Champaign. Lars is active in several pre-competitive organizations including IMI, PRISME Forum, Pistoia Alliance and EIT-health.